Biotech and Beyond…
Feinstein Kean Healthcare has always been synonymous with biotechnology communications.
Over more than 20 years, we have developed an unrivaled understanding of the unique business, regulatory and scientific challenges facing our industry. We have helped more than 350 biotech companies create and demonstrate value to their stakeholders.
Today, we work with a growing number of companies at all stages — start-up, developmental, and commercial — that are pushing new boundaries in scientific and business model innovation.
Molecular and Personalized Medicine…
From biotech, we moved naturally to the era of personalized medicine, becoming the first communications firm to establish a focus in that field. Again, we educated the media on underlying science, helped guide the strategy of the industry association, built bridges among previously-unconnected constituencies, and organized the events that have framed the debate around policy and regulatory issues.
Academic, Policy, Patient Advocacy Organizations…and Professional Societies
The key constituencies within the biomedical sphere have a dual communications challenge: to inform policymakers about innovation and the need for change, and to enhance their own membership and fund-raising capabilities. Feinstein Kean is woven into the fabric of these entities, helping them to position themselves and their message platforms to the right target audiences to achieve their goals. As a result of our contacts in the biotech and biopharmaceutical industries, we can also help to forge relationships across sectors that benefit everyone.
Corporate Branding and Positioning
For any company, branding is critically important — it reflects and shapes relationships with customers, media, and investors. When your brand drives your value, you need a partner who can get it right. We believe that visibility plus credibility equals value. And we have used our knowledge of the industry, and our contacts within it, to help build this value for hundreds of commercial- and development-stage companies and start-ups.
Image-Building for Non-Profit Organizations
Non-profit organizations ‘compete’ in a crowded space to gain member and donor attention. Although they do not seek ‘sales’, they want to be positioned as leaders, having the credibility needed to change the landscape. We have worked with a broad spectrum of such organizations – those that are just-formed and those in need of repositioning for a new generation – using our scientific and strategic credentials.
Health Industry Initiatives
As life sciences and health care converge, there are a variety of public-private collaborations emerging that cross traditional silos. Often, the participants must communicate across “time and space” in a cyber-community dedicated to a common cause. We use all our knowledge of these biomedical communities – and our digital influence skills – to build new ecosystems and drive the success of novel initiatives.
We have assisted countless biotech companies on the pathway to IPO, managing all communications before, during and after the offering. We can help you develop financing strategies, prepare for financial meetings, manage analyst briefings, comply with SEC disclosure regulations and effectively manage shareholder communications.
FKH understands the capital needs of the biotech industry, and we have a long history of assisting companies with multiple rounds of private and public financing. We can assist in the entire “run-up” process of establishing visibility and credibility among trade and business press and investors; building a presence among investors; and developing and executing post-financing PR and IR plans.
FKH helps to bring your company’s vision — and value — to life. We have helped many of our clients create compelling and differentiating presentations, and deliver them more effectively. We can help you tell your story, and tell it well. We are particularly adept at helping you to translate complex science for investors, and to animate it in a way that demonstrates its clinical and commercial value.
Visibility is a key determinant of value, especially for start-ups or companies whose technologies are still in the developmental stage. FKH can keep you and your company in front of analysts, partners, investors and the media through thought-leadership activities — prominent speaking engagements, bylined articles in influential trade publications, and introductions to our network of industry leaders. We help you identify the opportunities and audiences most closely aligned with your goals, provide communication training as needed, and manage all logistics.
Biotechnology Media Relations
Our life science media specialists enjoy strong relationships with top-tier journalists, and can help you tell your story in the right way at the right time. In addition to strategic counsel and crisis/issues management, we offer a full range of media relations services specializing in the biotech industry.
Biotechnology Scientific Publicity
FKH pioneered the use of science-based communications to help biotech companies build their visibility, credibility and value. We know how to extract maximum opportunity from conference presentations, journal publications and clinical and regulatory milestones — trial recruitment, publication of Phase II and III data, FDA filings, Advisory Committee meetings.
Product Launches and Promotions
It’s go-time: all elements of your business and communications plans must be ready and pointed in the right direction. FKH can help you get there, creating the roadmaps and timelines that can keep you on task and on target. We can develop the brand, engage the thought leaders, communicate the science, prepare the market, design and produce print, broadcast and online tools, work to ensure compliance with FDA and SEC guidelines, place the media stories and create awareness and anticipation among investors, policymakers and consumers.
Biotechnology Issues Management
FKH can help you manage issues before they become crises. We work with you to assess areas of vulnerability or controversy, then effectively confront and resolve them. We help our biotech clients prepare for and negotiate the complex legal, political and ethical issues associated with their technology and products. We secure briefings with top thought-leaders and journalists, and help you prepare for them; monitor media coverage and opposition activities and develop counter-strategies; and create comprehensive crisis communications plans that can help you steer through even the toughest storms. Our experience includes virtually every type of untoward event that can occur in the life of a biotech firm, from failed clinical trials, to FDA setbacks, to disruption of business deals.
For more information please contact:
Chief Executive Officer